Javascript must be enabled to continue!
Role of Antigen‐Presenting Cells in the Cytotoxic T‐Cell Response to Minor Histocompatibility Antigens (MIHA)
View through CrossRef
Although antigen‐presenting cells (APC) appear to be able to process minor histocompatibility antigens (MIHA) expressed on allogeneic cells and present them in association with intrinsic H‐2 of the APC in vivo, this does not occur in vitro. This could be due to fundamentally different mechanisms of antigen handling by APC in vitro, or it could represent compromised APC function. In order to distinguish these possibilities, we designed a system in which BALB/c spleen cells are transferred into an MIHA‐disparate irradiated host and allowed to reside for 2‐3 days; the spleen cells of the repopuiated host are removed and used as stimulator cells for the CTL response of primed BALB/c responder cells to DBA/2 MIHA. These cells are referred to as in vivo‐pulsed APC (IVP‐APC). Donor BALB/c cells are able to pick up DBA/2 MIHA after a passage in DBA/2 hosts and efficiently present MIHA to primed CTL precursors to generate DBA/2‐specific CTL. The donor cell type able lo pick up and present MIHA is present in spleen bul not thymus or bone marrow, is Thy‐1.2 negative, Ia+, and nylon wooladherent. Its stimulatory capacily is as efficient on a per cell basis as that of DBA/2 spleen cells. The generation of IVP‐APC requires repopulation of the irradiated host, which must express MIHA foreign to the BALB/c donor cells. When we attempled to generate IVP‐APC in H‐2 incompatible hosts, we found that, although the IVP‐APC could present H‐2 antigens, they were unable to present MIHA in association with intrinsic APC H‐2 antigens. Use of intra‐H‐2 recombinant strains as host mice indicated that compatibility of donor and host at the KI region of H‐2 was essential for the generation of IVP‐APC able to present apparently unprocessed MIHA to primed BALB/c responder cells. Thus, we were unable to reproduce the antigenprocessing function of APC encountering antigen in situ using an adoptive transfer method of pulsing APC with MIHA in vivo. In addition, we suggest that our results may impose constraints on the formulation of models to account for the association of MIHA with H‐2 antigens.
Title: Role of Antigen‐Presenting Cells in the Cytotoxic T‐Cell Response to Minor Histocompatibility Antigens (MIHA)
Description:
Although antigen‐presenting cells (APC) appear to be able to process minor histocompatibility antigens (MIHA) expressed on allogeneic cells and present them in association with intrinsic H‐2 of the APC in vivo, this does not occur in vitro.
This could be due to fundamentally different mechanisms of antigen handling by APC in vitro, or it could represent compromised APC function.
In order to distinguish these possibilities, we designed a system in which BALB/c spleen cells are transferred into an MIHA‐disparate irradiated host and allowed to reside for 2‐3 days; the spleen cells of the repopuiated host are removed and used as stimulator cells for the CTL response of primed BALB/c responder cells to DBA/2 MIHA.
These cells are referred to as in vivo‐pulsed APC (IVP‐APC).
Donor BALB/c cells are able to pick up DBA/2 MIHA after a passage in DBA/2 hosts and efficiently present MIHA to primed CTL precursors to generate DBA/2‐specific CTL.
The donor cell type able lo pick up and present MIHA is present in spleen bul not thymus or bone marrow, is Thy‐1.
2 negative, Ia+, and nylon wooladherent.
Its stimulatory capacily is as efficient on a per cell basis as that of DBA/2 spleen cells.
The generation of IVP‐APC requires repopulation of the irradiated host, which must express MIHA foreign to the BALB/c donor cells.
When we attempled to generate IVP‐APC in H‐2 incompatible hosts, we found that, although the IVP‐APC could present H‐2 antigens, they were unable to present MIHA in association with intrinsic APC H‐2 antigens.
Use of intra‐H‐2 recombinant strains as host mice indicated that compatibility of donor and host at the KI region of H‐2 was essential for the generation of IVP‐APC able to present apparently unprocessed MIHA to primed BALB/c responder cells.
Thus, we were unable to reproduce the antigenprocessing function of APC encountering antigen in situ using an adoptive transfer method of pulsing APC with MIHA in vivo.
In addition, we suggest that our results may impose constraints on the formulation of models to account for the association of MIHA with H‐2 antigens.
Related Results
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Optimization of a T cells education protocol to treat hematological cancers
Optimization of a T cells education protocol to treat hematological cancers
Abstract
Allogeneic hematopoietic stem cell transplantation is the sole curative treatment for patients with high-risk hematological cancers. Most of its activity re...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Cross-presentation of antigen by diverse subsets of murine liver cells
Cross-presentation of antigen by diverse subsets of murine liver cells
Antigen cross-presentation is a principal function of specialized antigen-presenting cells of bone marrow origin such as dendritic cells. Although these cells are sometimes known a...
Abstract B8: Adoptive immunotherapy targeting tumor heterogeneity in high-grade glioma (HGG)
Abstract B8: Adoptive immunotherapy targeting tumor heterogeneity in high-grade glioma (HGG)
Abstract
Background: Highly selective targeted T cell therapies using chimeric antigen receptors (CAR) are emerging as safe and effective modalities for the treatmen...
Construction and Molecular Characterization Of a T-Cell Receptor-Like Antibody and CAR-T Cells Specific For Minor Histocompatibility Antigen HA-1H
Construction and Molecular Characterization Of a T-Cell Receptor-Like Antibody and CAR-T Cells Specific For Minor Histocompatibility Antigen HA-1H
Selective graft-versus-tumor (GVT) reactivity with minimal risk of graft-versus-host disease (GVHD) following allogeneic stem cell transplantation is thought to be induced by targe...

